Shawn Yunayev, MD
Obstetrics & Gynecology · Brooklyn, NYNPI 1710293048
Payments from drug & device makers
Across 52 payments — averaging $255.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- Merz North America, Inc.$419
- Hologic Sales And Service, LLC$230
- Agile Therapeutics, Inc.$125
- Baxter Healthcare$125
- Evofem Biosciences, Inc.$124
- plus $642 from 11 others
What the payments were for
- Speaking & faculty fees$11,36185%
- Food & beverage$1,93015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $11,627 |
| Merz North America, Inc. | 4 | $419 |
| Hologic Sales And Service, LLC | 4 | $230 |
| Agile Therapeutics, Inc. | 1 | $125 |
| Baxter Healthcare | 1 | $125 |
| Evofem Biosciences, Inc. | 1 | $124 |
| Astellas Pharma US Inc | 1 | $122 |
| Sumitomo Pharma America, Inc. | 1 | $114 |
| Myriad Women's Health, Inc. | 1 | $97 |
| Channel Medsystems, Inc. | 1 | $76 |
| Galderma Laboratories, L.p. | 4 | $66 |
| Therapeuticsmd, Inc. | 2 | $47 |
| Lupin Inc. | 2 | $32 |
| Organon | 1 | $25 |
| Shield Therapeutics Inc | 1 | $23 |
| Coopersurgical, Inc. | 1 | $20 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,291 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibandronate Sodium | 16 | $294 |
| Fluconazole | 13 | $36 |
| Alendronate Sodium | 12 | $1 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Brooklyn
- Miriam CremerBrooklyn$196K
- Michael LewisBrooklyn$62K
- Kathleen MorrellBrooklyn$48K
- Ila DayanandaBrooklyn$43K
- Yi-Chun LeeBrooklyn$38K
- Mark DefazioBrooklyn$27K
- Marina FrimerBronx$8.5M
- Nicole NevadunskyBronx$2.5M
- Jin Hee KimNew York$1M
- Carolyn WesthoffNew York$935K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.